Skip to content

John F Cryan

4 papers in the library · 99 citations · publishing 2013-2023

Papers

Sort Most recent Most cited

Seeking the Psilocybiome: Psychedelics meet the microbiota-gut-brain axis.

International journal of clinical and health psychology : IJCHP 2023 John R. Kelly, Gerard Clarke, Andrew Harkin et al. 33 citations

Moving towards a systems psychiatry paradigm embraces the inherent complex interactions across all levels from micro to macro and necessitates an integrated approach to treatment. Cortical 5-HT2A receptors are key primary targets for the effects of serotonergic psychedelics. However, the therapeutic mechanisms underlying psychedelic therapy are complex and traverse molecular, cellular, and...

The 4E approach to the human microbiome: Nested interactions between the gut-brain/body system within natural and built environments.

BioEssays : news and reviews in molecular, cellular and developmental biology June 1, 2022 Ismael Palacios-García, Gwynne A Mhuireach, Aitana Grasso-Cladera et al. 13 citations

The complexity of the human mind and its interaction with the environment is one of the main epistemological debates throughout history. Recent ideas, framed as the 4E perspective to cognition, highlight that human experience depends causally on both cerebral and extracranial processes, but also is embedded in a particular sociomaterial context and is a product of historical accumulation of...

DOI: 10.1002/bies.202100249 (opens in new tab) Full text (opens in new tab) 4e cognition Built environment Gut-brain axis Mental health +1

Kynurenine pathway metabolism and the neurobiology of treatment-resistant depression: Comparison of multiple ketamine infusions and electroconvulsive therapy.

Journal of Psychiatric Research February 10, 2018 Andrew P. Allen, Maura Naughton, J. Dowling et al. 53 citations

Current first-line antidepressants can take weeks or months to decrease depressive symptoms. Low dose ketamine, an N-methyl-D-aspartate (NMDA) receptor antagonist, shows potential for a more rapid antidepressant effect, with efficacy also evident in previously treatment-resistant populations. However, a greater understanding of the physiological mechanisms underlying such effects is required....

microRNAs as novel antidepressant targets: converging effects of ketamine and electroconvulsive shock therapy in the rat hippocampus

The International Journal of Neuropsychopharmacology September 1, 2013 Richard M. O'Connor, Susan Grenham, Timothy G Dinan et al.

Abstract: Early-life stress is a main contributory factor to the onset of depression. Treatments remain inadequate and as such, a large unmet medical need for novel therapeutics remains. Impeding advancement is the poor understanding of the molecular pathology. microRNAs (miRNAs) are novel regulators of gene expression. A paucity of information regarding their role in depressive pathology and...